Halioua-Haubold, C., Jolly, J., Smith, J., Villanueva, R., Brindley, D., & MacLaren, R. (2019). Potential lifetime quality of life benefits of choroideremia gene therapy: Projections from a clinically informed decision model. Springer Nature.
Citace podle Chicago (17th ed.)Halioua-Haubold, C-L, JK Jolly, JA Smith, R. Villanueva, DA Brindley, a RE MacLaren. Potential Lifetime Quality of Life Benefits of Choroideremia Gene Therapy: Projections from a Clinically Informed Decision Model. Springer Nature, 2019.
Citace podle MLA (9th ed.)Halioua-Haubold, C-L, et al. Potential Lifetime Quality of Life Benefits of Choroideremia Gene Therapy: Projections from a Clinically Informed Decision Model. Springer Nature, 2019.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..